Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Update

Advanced Biomed Inc. (NASDAQ:ADVB) was the recipient of a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 16,357 shares, a decline of 56.2% from the August 15th total of 37,364 shares. Currently, 1.4% of the company’s shares are sold short. Based on an average daily volume of 272,520 shares, the days-to-cover ratio is presently 0.1 days.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of Advanced Biomed to a “hold” rating in a research report on Saturday, August 22nd. Weiss Ratings raised Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 23rd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Advanced Biomed Price Performance

Shares of ADVB opened at $7.95 on Wednesday. The firm has a market capitalization of $13.12 million, a price-to-earnings ratio of 1.74 and a beta of -0.29. Advanced Biomed has a 1-year low of $3.61 and a 1-year high of $24.23. The company has a 50-day moving average of $8.67 and a 200 day moving average of $6.20.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.